Page last updated: 2024-11-05

talactoferrin alfa and Hemorrhagic Shock

talactoferrin alfa has been researched along with Hemorrhagic Shock in 1 studies

talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006

Research Excerpts

ExcerptRelevanceReference
"These results provide a proof of principle that prophylactic dosing of oral talactoferrin can potentially protect the gut in a T/HS model and limit the production of biologically active factors in rat gastrointestinal tissue subjected to ischemia-reperfusion-type injuries."7.80Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph. ( Chandler, B; Deitch, EA; Feketova, E; Qin, Y; Quackenbush, EJ; Son, JY, 2014)
"These results provide a proof of principle that prophylactic dosing of oral talactoferrin can potentially protect the gut in a T/HS model and limit the production of biologically active factors in rat gastrointestinal tissue subjected to ischemia-reperfusion-type injuries."3.80Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph. ( Chandler, B; Deitch, EA; Feketova, E; Qin, Y; Quackenbush, EJ; Son, JY, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Son, JY1
Chandler, B1
Feketova, E1
Qin, Y1
Quackenbush, EJ1
Deitch, EA1

Other Studies

1 other study available for talactoferrin alfa and Hemorrhagic Shock

ArticleYear
Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph.
    The Journal of surgical research, 2014, Volume: 187, Issue:1

    Topics: Administration, Oral; Animals; Ileum; Lactoferrin; Laparotomy; Lymph; Lymphatic System; Male; Neutro

2014